Literature DB >> 9506978

Characterization of the residues phosphorylated in vitro by different C-terminal domain kinases.

S Trigon1, H Serizawa, J W Conaway, R C Conaway, S P Jackson, M Morange.   

Abstract

The C-terminal part of the largest subunit of eukaryotic RNA polymerase II is composed solely of the highly repeated consensus sequence Tyr1-Ser2-Pro3-Thr4-Ser5-Pro6-Ser7. This domain, called the C-terminal domain (CTD), is phosphorylated mostly at serine residues during transcription initiation, but the precise role of this phosphorylation remains controversial. Several protein kinases are able to phosphorylate this sequence in vitro. The aim of this work was to define the positions of the amino acids phosphorylated by four of these CTD kinases (transcription factor (TF) IIH-kinase, DNA-dependent protein kinase, and the mitogen-activated protein kinases ERK1 and ERK2) and to compare the specificity of these different protein kinases. We show that TFIIH kinase and the mitogen-activated protein kinases phosphorylate only serine 5 of the CTD sequence, whereas DNA-dependent protein kinase phosphorylates serines 2 and 7. Among the different CTD kinases, only TFIIH kinase is appreciably more active on two repeats of the consensus sequence than on one motif. These in vitro results can provide some clues to the nature of the protein kinases responsible for the in vivo phosphorylation of the RNA polymerase CTD. In particular, the ratio of phosphorylated serine to threonine observed in vivo cannot be explained if TFIIH kinase is the only protein kinase involved in the phosphorylation of the CTD.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9506978     DOI: 10.1074/jbc.273.12.6769

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  57 in total

1.  Transcription elongation factor hSPT5 stimulates mRNA capping.

Authors:  Y Wen; A J Shatkin
Journal:  Genes Dev       Date:  1999-07-15       Impact factor: 11.361

Review 2.  Phosphorylation in transcription: the CTD and more.

Authors:  T Riedl; J M Egly
Journal:  Gene Expr       Date:  2000

3.  Evolution of the RNA polymerase II C-terminal domain.

Authors:  John W Stiller; Benjamin D Hall
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-23       Impact factor: 11.205

Review 4.  RNA polymerase II carboxy-terminal domain kinases: emerging clues to their function.

Authors:  Gregory Prelich
Journal:  Eukaryot Cell       Date:  2002-04

5.  The Tat/TAR-dependent phosphorylation of RNA polymerase II C-terminal domain stimulates cotranscriptional capping of HIV-1 mRNA.

Authors:  Meisheng Zhou; Longwen Deng; Fatah Kashanchi; John N Brady; Aaron J Shatkin; Ajit Kumar
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-20       Impact factor: 11.205

6.  Inhibition of HTLV-1 transcription by cyclin dependent kinase inhibitors.

Authors:  Lai Wang; Longwen Deng; Kaili Wu; Cynthia de la Fuente; Dai Wang; Kylene Kehn; Anil Maddukuri; Shanese Baylor; Francisco Santiago; Emmanuel Agbottah; Sylviane Trigon; Michel Morange; Renaud Mahieux; Fatah Kashanchi
Journal:  Mol Cell Biochem       Date:  2002-08       Impact factor: 3.396

7.  The TFIIB tip domain couples transcription initiation to events involved in RNA processing.

Authors:  Khiem Tran; Jay D Gralla
Journal:  J Biol Chem       Date:  2010-09-29       Impact factor: 5.157

8.  Herpes simplex virus type 1 infection leads to loss of serine-2 phosphorylation on the carboxyl-terminal domain of RNA polymerase II.

Authors:  Kathryn A Fraser; Stephen A Rice
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

9.  The ATM Kinase Restrains Joining of Both VDJ Signal and Coding Ends.

Authors:  Katheryn Meek; Yao Xu; Caleb Bailie; Kefei Yu; Jessica A Neal
Journal:  J Immunol       Date:  2016-08-29       Impact factor: 5.422

10.  RNA polymerase II C-terminal heptarepeat domain Ser-7 phosphorylation is established in a mediator-dependent fashion.

Authors:  Stefan Boeing; Caroline Rigault; Martin Heidemann; Dirk Eick; Michael Meisterernst
Journal:  J Biol Chem       Date:  2009-11-09       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.